Back to Search
FRANCESCA BAGNATO, M.D.
M.D.
Neurology Physician
NPI: 1801189329IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
MD53414(TN)
CMS Specialties
PrimaryNEUROLOGY
Education
OTHER
Class of 1996
Research & Publications (20)
Tissue-specific imaging is a robust methodology to differentiate in vivo T1 black holes with advanced multiple sclerosis-induced damage.
PMID 19406765·AJNR Am J Neuroradiol·2009
8-other
Multisequence-imaging protocols to detect cortical lesions of patients with multiple sclerosis: observations from a post-mortem 3 Tesla imaging study.
PMID 19394970·J Neurol Sci·2009
8-other
Thalamic involvement and its impact on clinical disability in patients with multiple sclerosis: a diffusion tensor imaging study at 3T.
PMID 19369608·AJNR Am J Neuroradiol·2009
8-other
Uncovering and characterizing multiple sclerosis lesions: the aid of fluid-attenuated inversion recovery images in the presence of gadolinium contrast agent.
PMID 19187471·J Neuroimaging·2009
8-other
Heterogeneity in response to interferon beta in patients with multiple sclerosis: a 3-year monthly imaging study.
PMID 19001157·Arch Neurol·2009
3-trial
The effect of interferon beta-1b on size of short-lived enhancing lesions in patients with multiple sclerosis.
PMID 18990070·Expert Opin Biol Ther·2008
8-other
A case study on the effect of neutralizing antibodies to interferon beta 1b in multiple sclerosis patients followed for 3 years with monthly imaging.
PMID 17666095·Clin Exp Immunol·2007
8-other
The effect of interferon-beta on black holes in patients with multiple sclerosis.
PMID 17665995·Expert Opin Biol Ther·2007
6-review
An exploratory study on interferon beta dose effect in reducing size of enhancing lesions in multiple sclerosis.
PMID 17439903·Mult Scler·2007
2-rct
Pharmacodynamics of interferon beta in multiple sclerosis patients with or without serum neutralizing antibodies.
PMID 17420930·J Neurol·2007
3-trial
Expression of biomarkers of interferon type I in patients suffering from chronic diseases.
PMID 17223968·Clin Exp Immunol·2007
8-other
Brain volume measurements in patients with human T-cell lymphotropic virus-1-associated tropical spastic paraparesis.
PMID 17065127·J Neurovirol·2006
8-other
Neutralising antibodies to IFN-beta in patients with multiple sclerosis.
PMID 16856799·Expert Opin Biol Ther·2006
6-review
Effect of MRI coregistration on serial short-term brain volume changes in multiple sclerosis.
PMID 16687053·Neurol Res·2006
4-observational
Clinical and imaging metrics for monitoring disease progression in patients with multiple sclerosis.
PMID 16623658·Expert Rev Neurother·2006
6-review
A novel assay to detect low-titred antibodies to interferon beta in multiple sclerosis patients.
PMID 16608120·New Microbiol·2006
8-other
Conventional magnetic resonance imaging features in patients with tropical spastic paraparesis.
PMID 16338746·J Neurovirol·2005
8-other
Interferon-beta-1b effects on re-enhancing lesions in patients with multiple sclerosis.
PMID 16320725·Mult Scler·2005
3-trial
Considerations on the development of serum antibodies to interferon-beta.
PMID 16240689·New Microbiol·2005
6-review
Multidisciplinary approach for diagnosing syncope: a retrospective study on 521 outpatients.
PMID 16227562·J Neurol Neurosurg Psychiatry·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 3810 Bedford Ave
Nashville, TN 37215 - Phone
- (615) 322-3000
Quick Facts
- NPI
- 1801189329
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 30
- Publications
- 20
Are you this provider?
Claim Your Profile